Caribou Biosciences, Inc. (CRBU) › Operating Cash FlowCaribou Biosciences, Inc. (CRBU) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2019: -$32.01M2020: -$33.22M2021: -$32.52M2022: -$90.97M2023: -$93.29M2024: -$138.20M2025: -$110.99M-$110.99M2019Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$110.99M+19.7%2024-$138.20M-48.1%2023-$93.29M-2.6%2022-$90.97M-179.7%2021-$32.52M+2.1%2020-$33.22M-3.8%2019-$32.01M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share